FN · Fabrinet
$570.22
+3.73 (+0.66%)
At close · Aug 14
Market Cap
$20.43B
Shares
35.83M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Seamus Grady | Chief Executive Officer | $11,944,135 |
| Dr. Harpal Gill | President and Chief Operating Officer | $10,027,946 |
| Csaba Sverha | Executive Vice President, Chief Financial Officer | $4,629,697 |
| Edward T. Archer | Executive Vice President, Sales & Marketing | $3,524,977 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Seamus Grady | Chief Executive Officer | $11,082,191 |
| Dr. Harpal Gill | President and Chief Operating Officer | $8,925,933 |
| Csaba Sverha | Executive Vice President, Chief Financial Officer | $4,118,881 |
| Edward T. Archer | Executive Vice President, Sales & Marketing | $3,335,359 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Seamus Grady | Chief Executive Officer | $10,527,608 |
| Dr. Harpal Gill | President and Chief Operating Officer | $8,242,121 |
| Csaba Sverha | Executive Vice President, Chief Financial Officer | $4,054,937 |
| Edward T. Archer | Executive Vice President, Sales & Marketing | $3,313,539 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Seamus Grady | Chief Executive Officer | $9,936,955 |
| Dr. Harpal Gill | President and Chief Operating Officer | $7,616,070 |
| Csaba Sverha | Executive Vice President, Chief Financial Officer | $3,700,933 |
| Edward T. Archer | Executive Vice President, Sales & Marketing | $3,077,460 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| David T. Mitchell | Chairman | Retired | 2025-10-17 |
| Caroline Dowling | Class I director | Appointed | 2025-10-16 |
| Rollance Olson | Board of Directors | Retired | 2025-05-27 |
| Forbes I.J. Alexander | Class III director | Appointed | 2024-06-14 |
Key facts
CIK
1408710
CUSIP
G3323L100
13F (30d)
706 filings
685 filers
Visit website
Investor relations